Business Update5 May 2026, 07:41 pm
Carbogen Amcis Shanghai Passes NMPA GMP Inspection
AI Summary
Dishman Carbogen Amcis Ltd's subsidiary, CARBOGEN AMCIS (Shanghai) Co. Ltd., successfully completed an unannounced Good Manufacturing Practice (GMP) inspection by China’s National Medical Products Administration (NMPA). The inspection, which included an on-site assessment of API manufacturing operations and the site’s Quality System, concluded without observations. This outcome validates the company's commitment to maintaining high GMP standards and reinforces confidence in the Shanghai site as a reliable partner for customers worldwide.
Key Highlights
- CARBOGEN AMCIS Shanghai successfully completes NMPA GMP inspection.
- The inspection found no observations, highlighting robust GMP compliance.
- The Shanghai facility supports API manufacturing and process development.
- The successful inspection supports the company’s growth in China.
- The unannounced inspection confirms GMP execution consistency.